Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TOPPIT: Plasma Transfusion Prior to Invasive Procedures
NCT02561026Phase 3Unknown
- Sponsor
- Ottawa Hospital Research Institute
- Start
- Jan 2016
- Primary completion
- Aug 2018
- Modality
- Recombinant Proteins and Enzymes, Tissue Cells
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of fresh-frozen plasma in coagulopathy (2 arms), sponsored by Ottawa Hospital Research Institute. Primary endpoint: Recruitment feasibility. Status: unknown.
02
Drugs
fresh-frozen plasma
03
Conditions
coagulopathy
Beyond the preview
Go deeper on NCT02561026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02561026.